Cicala Peter
SEC insider (Form 3/4/5 filer). CIK 0002011534. Director at Ernexa Therapeutics Inc. (ERNA). 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in CAMBRIDGE, MA.
Companies Cicala Peter has filed insider reports for
- Ernexa Therapeutics Inc. (ERNA): Director
Cicala Peter
CIK: 0002011534
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ERNA
Ernexa Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Aug 31, 2026ERNA
Ernexa Therapeutics Inc.
AwardDirectStock Option (Right to buy)
5.9K shares- - Aug 31, 2026ERNA
Ernexa Therapeutics Inc.
AwardDirectStock Option (Right to buy)
5.1K shares- - Feb 7, 2025ERNA
Eterna Therapeutics Inc.
AwardDirectStock Option (Right to buy)
51.5K shares-
1-3 of 3 transactions